First report of observation trial about impact of bisphosphonate`s treatment to the quality of life breast cancer patient with bone metastases
Increasing survival of oncology patients depends on early diagnostics, developing the new technologies of the treatment and the new drugs. It allows finding out more and more patients with bone metastases. So the answers to the questions about bisphosphonate`s duration, complication of the treatment...
Saved in:
Main Authors: | O. V. Zelenova, L. V. Bolotina, L. Yu. Nikitina, M. V. Chernikov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2014-07-01
|
Series: | Опухоли женской репродуктивной системы |
Subjects: | |
Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/106 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of the effects of zoledronic acid versus denosumab on bone metabolism, inflammatory response, and immunoglobulins in breast cancer patients with bone metastases
by: Zhang Xian, et al.
Published: (2025-01-01) -
PREVENTION OF COMPLICATIONS IN CASTRATE-REFRACTORY PROSTATE CANCER PATIENTS WITH BONE METASTASES
by: K. M. Nushko, et al.
Published: (2015-10-01) -
Comparative analysis of Denosumab and Zoledronic acid in advanced breast cancer patients receiving CDK4/6 inhibitors
by: Roberta Scafetta, et al.
Published: (2025-08-01) -
BISPHOSPHONATES IN PROPHYLAXIS OF SKELETAL-RELATED ADVERSE EVENTS IN PATIENTS WITH CASTRATION-REFRACTORY PROSTATE CANCER
by: E. Yu. Safronova, et al.
Published: (2016-06-01) -
ADJUVANT TREATMENT WITH BIPHOSPONATES IN COMPLEX THERAPY OF PAPILLARY THYROID CANCER BONE METASTASES
by: A. D. Kaprin, et al.
Published: (2017-09-01)